The concept of innovative drugs is repeatedly active, and both Xintian Pharmaceutical and Jinling Pharmaceutical have consecutively hit the daily limit.

The concept of innovative drugs is repeatedly active, New Tian Pharmaceutical and Jinling Pharmaceutical both hit the limit up for two consecutive days, Baihua Medicine and Wanzefeng shares also hit the limit up, Sairui Biology, Junshi Biology, Yinosi, Yangguangnuo and all followed the trend up.